Maraviroc for treatment-naive patients with HIV-1 infection: is the glass half empty or half full?

J Infect Dis. 2010 Mar 15;201(6):797-9. doi: 10.1086/650701.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • CCR5 Receptor Antagonists*
  • Cyclohexanes / pharmacology
  • Cyclohexanes / therapeutic use*
  • Drug Resistance, Viral
  • HIV Infections / drug therapy*
  • HIV Infections / prevention & control
  • HIV-1 / drug effects*
  • Humans
  • Maraviroc
  • Triazoles / pharmacology
  • Triazoles / therapeutic use*

Substances

  • Antiviral Agents
  • CCR5 Receptor Antagonists
  • Cyclohexanes
  • Triazoles
  • Maraviroc